Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,047,480
+$22,930 QoQ
Shares Held
3,741
-2.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#459
of 1,044 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $3,045,618 across 9 Diagnostics & Research names. LH ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
This page
|
3,741 | $1,047,480 | |
| 2 | DGX |
Quest Diagnostics Inc
|
4,707 | $997,648 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,110 | $587,844 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
452 | $226,614 | |
| 5 | DHR |
Danaher Corp /De/
|
674 | $128,383 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
69 | $36,324 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
100 | $19,322 | |
| 8 | NTRA |
Natera, Inc.
|
6 | $1,628 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,047,480 | 3,741 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,024,550 | 3,840 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $963,379 | 3,840 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,000,688 | 3,812 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $901,634 | 3,874 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $888,385 | 3,874 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $865,761 | 3,874 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $766,011 | 3,764 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||